Our recent study demonstrated that a higher continuous renal replacement therapy (CRRT) dose did not improve the mortality rate in patients with septic acute kidney injury (AKI).1 Considering the insufficient evidence of survival benefit and the expense of high-dose CRRT,2,3 Sato et al4 suggest that lower-dose CRRT, even